Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Prostatic Neoplasms × abiraterone × Clear all

Phase

Status

Sponsor Class

OTHER 35 INDUSTRY 27 OTHER_GOV 1 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Adenocarcinoma 1

Interventions

bicalutamide 18 Docetaxel 17 Radiotherapy 16 Goserelin 16 Leuprolide 12 Flutamide 12 Prednisone 9 Radiotherapy, Conformal 8 Radiotherapy, Intensity-Modulated 7 Gonadotropin-Releasing Hormone 7 Estramustine 7 Buserelin 6 Paclitaxel 5 Brachytherapy 5 Androgen Antagonists 5 enzalutamide 4 Triptorelin Pamoate 4 orteronel 3 nilutamide 3 darolutamide 3 apalutamide 3 Selenium 3 Radiation 3 Mitoxantrone 3 Iodine-125 3 Carboplatin 3 Amplified Fragment Length Polymorphism Analysis 3 tremelimumab 2 luprolide acetate gel depot 2 durvalumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06592924 2026-01-14

TRIPLE-SWITCH

Canadian Cancer Trials Group

Phase 3 Recruiting

Adenocarcinoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡